Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Asset Resilience Ratio
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd asset resilience ratio. Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126) has an Asset Resilience Ratio of 0.31% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 301126 days of operational coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (2022–2025)
Asset resilience ratio of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd from 2022 to 2025. This chart shows how Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's Asset Resilience Ratio has changed over time. Read Hunan Dajiaweikang Pharmaceutical Indust debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Hunan Dajiaweikang Pharmaceutical Indust total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥19.82 Million | 0.31% |
| Total Liquid Assets | CN¥19.82 Million | 0.31% |
Asset Resilience Insights
- Limited Liquidity: Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd maintains only 0.31% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Industry Peers by Asset Resilience Ratio
Compare Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408 |
Pharmaceutical Retailers | 3.57% |
|
Oriola-KD Oyj B
HE:OKDBV |
Pharmaceutical Retailers | 14.13% |
|
Raia Drogasil S.A
SA:RADL3 |
Pharmaceutical Retailers | 0.46% |
|
Empreendimentos Pague Menos S.A
SA:PGMN3 |
Pharmaceutical Retailers | 0.00% |
|
d1000 Varejo Farma Participações S.A
SA:DMVF3 |
Pharmaceutical Retailers | 2.05% |
|
High Tide Inc
V:HITI |
Pharmaceutical Retailers | 0.02% |
|
Yifeng Pharmacy
SHG:603939 |
Pharmaceutical Retailers | 19.16% |
|
Dashenlin Pharm Grp Co Ltd
SHG:603233 |
Pharmaceutical Retailers | 0.80% |
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Asset Resilience Ratio by Year (2022–2025)
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd asset resilience ratio by year from 2022 to 2025. The table below shows the annual Asset Resilience Ratio data for Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 0.16% | CN¥9.82 Million ≈ $1.44 Million |
CN¥6.34 Billion ≈ $927.29 Million |
-2.39pp |
| 2022-12-31 | 2.54% | CN¥100.00 Million ≈ $14.63 Million |
CN¥3.93 Billion ≈ $575.29 Million |
-- |
About Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd engages in the wholesale and retail of pharmaceuticals products in China. It provides raw materials, biological products, chemical drugs, Chinese herbal medicines, medical devices, and other products. The company also offers Chinese patent medicines in the form of granules, capsules, particles, tablets, slices, and pills; foods, such as beverages… Read more